AAIPharma Services

What AAIPharma Services does

AAIPharma Services, operating under the brand Alcami Corporation, is a US-based contract development and manufacturing organization (CDMO) headquartered in North Carolina with 45+ years of experience serving pharmaceutical and biotechnology companies. The firm operates three integrated service pillars: drug product manufacturing (including sterile fill-finish, oral solid dose, formulation development, and — following the May 2026 acquisition of Tjoapack — packaging and labeling); laboratory services (analytical method development, microbiology testing, compendial testing, and biologics); and pharmaceutical storage and support services (cGMP storage, metrology and calibration, commissioning/qualification/validation, environmental monitoring and cleanroom services, on-site pharma services, and equipment rentals). Together these offerings span the pharmaceutical lifecycle from preclinical development through commercial supply.

The business model is fee-for-service / project-based CDMO revenue, with pricing quote-based and not publicly disclosed. Services are sold through direct enterprise field sales targeting pharmaceutical and biotech companies, including long-term manufacturing partnerships that span preclinical through commercial supply. The firm markets itself through digital content (webinars, whitepapers, case studies, eBooks) on its website and engages on LinkedIn and X for B2B awareness. No public revenue figures are disclosed, but the company employs 501-1,000 people and is privately held by a consortium of healthcare-focused private equity sponsors — GHO Capital, The Vistria Group, and Ampersand Capital Partners — with operating geographies centered in the United States.

Alcami's strategic posture is best characterized as a multi-service mid-market CDMO platform pursuing inorganic growth and capability expansion, evidenced by the recent Tjoapack acquisition and active content marketing around emerging modalities like cell and gene therapies. The leadership team includes CEO Ludo Reynders and VP Dean Shirazi, though broader management details are not disclosed in the source data.

Name

AAIPharma Services

Legal name

Alcami Corporation

Website

https://aaipharma.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

501–1,000 employees

Short description

AAIPharma Services (operating as Alcami Corporation) is a US-based contract development and manufacturing organization (CDMO) headquartered in North Carolina providing sterile fill-finish, oral solid dose manufacturing, analytical laboratory services, and cGMP storage to pharmaceutical and biotechnology companies across preclinical through commercial supply stages.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Packaging and Labeling Services (561910)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Equipment Rental & Leasing, Nec (7359)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

akta.pro secondary industries

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB), Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

Keywords

• Pharmaceutical contract manufacturing
• Sterile fill-finish services
• Analytical laboratory testing
• Oral solid dose manufacturing
• CGMP pharmaceutical storage

Headquarters

HQ city

Wilmington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Supply Chain

Revenue model

1. Drug Product Manufacturing Services: Fee-for-service manufacturing revenue from sterile fill-finish and oral solid dose manufacturing, spanning preclinical through commercial supply stages
2. Laboratory Services: Revenue from analytical method development, microbiology testing, compendial testing, and biologics services offered as standalone or bundled with manufacturing
3. Pharmaceutical Storage & Support Services: cGMP storage services, metrology and calibration, validation services, environmental monitoring, and equipment rentals and sales

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

AAIPharma Services (operating as Alcami Corporation) is a US-based contract development and manufacturing organization (CDMO) that provides fully integrated pharmaceutical services spanning drug product manufacturing (sterile fill-finish and oral solid dose), analytical and microbiological laboratory services, and cGMP pharmaceutical storage and support services. The company serves pharmaceutical and biotech clients from preclinical development through commercial supply, with over 45 years of industry experience.

Product overview

Alcami is a contract development and manufacturing organization (CDMO) offering a fully integrated portfolio of pharmaceutical services organized into three core service lines: Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage & Services. The Drug Product Manufacturing division includes Sterile Fill Finish Manufacturing, Oral Solid Dose Manufacturing, Packaging & Labeling (enhanced by the acquisition of Tjoapack), and Formulation Development. Laboratory Services encompasses Analytical Method Development, Microbiology Testing, Compendial Testing, and Biologics services. The Pharmaceutical Storage & Services line provides cGMP storage along with support services including Metrology & Calibration, Commissioning Qualification and Validation (CQV), Environmental Monitoring & Cleanroom services, On-Site Pharma Services, and Equipment Rentals and Sales. These services can be used as standalone offerings or bundled together for integrated pharmaceutical development and manufacturing support.

Differentiator

Problem solved

Functional benefit

Products and services

• Drug Product Manufacturing Comprehensive sterile fill-finish and oral solid dose drug product manufacturing and support services for pharmaceutical and biotech companies, spanning from preclinical development through commercial supply.
• Laboratory Services Extensive analytical and microbiological laboratory services for pharmaceutical and biotech companies, available as standalone offerings or bundled with drug product manufacturing engagements.
• Pharmaceutical Storage & Services Secure and reliable cGMP storage for pharmaceuticals and biologics, along with in-house and onsite calibration, validation services, environmental monitoring, and equipment rentals and sales.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

One partnership is on record.

• TjoapackcoreStrategic or Co-development Partner · 5 May 2026Alcami completed acquisition of Tjoapack, expanding their contract manufacturing and packaging capabilities.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• CordenPharma: Specialty CDMO serving pharma clients with API synthesis, sterile injectable, oral solid dose, and peptide manufacturing capabilities — directly comparable to Alcami's drug product manufacturing services.
• Catalent: Large global CDMO offering sterile fill-finish, oral solid dose, and biologics services; directly overlaps with Alcami's drug product manufacturing and lab services portfolio, though at significantly larger scale.
• Lonza Group: One of the world's largest CDMOs spanning small molecules, biologics, and cell/gene therapy; competes with Alcami particularly in sterile fill-finish and oral solid dose CDMO work for pharma clients.
• Thermo Fisher Scientific (Patheon CDMO): Patheon, the CDMO division of Thermo Fisher, offers drug product development, sterile fill-finish, OSD, and integrated clinical/commercial manufacturing services directly competitive with Alcami.
• Recipharm: European-headquartered CDMO specializing in sterile fill-finish, OSD, and biologics manufacturing; competes for the same pharma client contracts as Alcami, particularly in late-stage and commercial supply.
• Cambrex: Small-molecule API and drug product CDMO focused on analytical services, formulation development, and commercial manufacturing — a direct competitor in Alcami's sweet spot of small-molecule OSD and analytical testing.
• PCI Pharma Services: CDMO offering drug product manufacturing, packaging, and clinical supply services; with its strong packaging focus, it is a particularly close peer to Alcami following the Tjoapack acquisition.
• Curia (formerly AMRI): CDMO providing contract development, API manufacturing, and drug product services across small molecules and biologics; competes with Alcami for pharma/biotech contract manufacturing engagements.

Broad incumbents

• West Pharmaceutical Services: Broad incumbent supplying primary packaging components, drug delivery, and containment solutions to injectable drug manufacturers; comparable to the packaging/labeling capabilities Alcami gained through Tjoapack.

Regional players

• Aenova Group: European-headquartered CDMO offering solid dosage forms, sterile fill-finish, and packaging services; similar integrated CDMO model to Alcami but primarily serving Europe rather than the US market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/AAIPharma
• LinkedInlinkedin.com/company/14807
• Facebookfacebook.com/AAIPharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AAIPharma Services